Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
State Program and Technical Manager, Cap TB Project, AP/TS Unit, Solidarity and Action Against The HIV Infection in India (SAATHII).
Indian J Cancer. 2022 Jan-Mar;59(1):54-64. doi: 10.4103/ijc.IJC_576_19.
">Breast and cervical cancers are the two leading causes of cancer-related morbidity and mortality in India. Early diagnosis of these cancers through screening offers the best chance to achieve successful treatment outcomes. Hence, the current study was done to determine the prevalence and predictors of breast and cervical cancer screening among women aged 30-49 years in India.
We have analyzed the most recent National Family Health Survey-4 data (NFHS-4) gathered from Demographic Health Survey program. Stratification and clustering in the sample design were accounted using svyset command. Adjusted prevalence ratio (aPR) with 95% confidence interval (CI) was reported.
In total, 336,777 women aged 30-49 years were included. Proportion of women aged 30-49 years with history of breast cancer examination in their lifetime was 12.9% (95% CI: 12.6-13.2%), while it was 29.8% (95% CI: 29.3-30.3%) for cervical cancer. It was found that women aged 45-49 years (aPR=1.09), married (aPR=2.18), higher educational level (aPR=1.28), richest quantile (aPR=1.96), no history of pill use (aPR=1.24), obese (aPR=1.06), and healthy dietary habits (aPR=1.47) were more likely to be screened for breast cancer. Predictors for cervical cancer screening were higher age group (aPR=1.06), married (aPR=2.94), secondary educational level (aPR=1.05), richest quantile (aPR=2.24), nonpill user (aPR=1.24), nontobacco user (aPR=1.07), and lower parity (aPR=1.09).
A total of 1 out of 10 women in reproductive age group were screened for breast cancer while less than one in three for cervical cancer. Hence, it is important to spread awareness and increase access to screening services to achieve early diagnosis and better treatment outcomes.
乳腺癌和宫颈癌是印度癌症相关发病率和死亡率的两个主要原因。通过筛查早期诊断这些癌症为实现成功治疗结果提供了最佳机会。因此,本研究旨在确定印度 30-49 岁女性乳腺癌和宫颈癌筛查的流行率和预测因素。
我们分析了最近的国家家庭健康调查-4 数据(NFHS-4),这些数据来自人口健康调查计划。使用 svyset 命令对样本设计中的分层和聚类进行了处理。报告了调整后的患病率比(aPR)及其 95%置信区间(CI)。
共有 336777 名 30-49 岁的女性被纳入研究。一生中曾接受过乳腺癌检查的 30-49 岁女性比例为 12.9%(95%CI:12.6-13.2%),而宫颈癌的比例为 29.8%(95%CI:29.3-30.3%)。研究发现,45-49 岁的女性(aPR=1.09)、已婚(aPR=2.18)、较高的教育水平(aPR=1.28)、最富裕的阶层(aPR=1.96)、无避孕药使用史(aPR=1.24)、肥胖(aPR=1.06)和健康的饮食习惯(aPR=1.47)更有可能接受乳腺癌筛查。宫颈癌筛查的预测因素包括年龄较大(aPR=1.06)、已婚(aPR=2.94)、中等教育水平(aPR=1.05)、最富裕的阶层(aPR=2.24)、非避孕药使用者(aPR=1.24)、非烟草使用者(aPR=1.07)和较低的生育次数(aPR=1.09)。
在生育年龄组中,每 10 名女性中只有 1 名接受了乳腺癌筛查,而不到 3 名女性接受了宫颈癌筛查。因此,重要的是要提高认识并增加获得筛查服务的机会,以实现早期诊断和更好的治疗结果。